Understanding Your Diagnosis
At a Glance
Adult-onset autosomal recessive sideroblastic anemia is an inherited problem with making hemoglobin: iron becomes trapped in immature red blood cells, creating ring sideroblasts. A later diagnosis can reflect milder gene effects or delayed testing, and iron overload still needs monitoring.
Receiving a diagnosis of Adult-Onset Autosomal Recessive Sideroblastic Anemia can bring a complex mix of emotions. For many, it marks the end of a long “diagnostic odyssey”—a period of months or years spent searching for answers while dealing with unexplained fatigue and anemia [1][2].
This diagnosis means your body has a rare, inherited difficulty producing healthy red blood cells. While “congenital” implies the genetic variant was present from birth, many genetic forms of this condition are not clinically recognized or diagnosed until adulthood [3][4]. This delay does not mean you have a “new” mutation; rather, it often reflects how your specific genetic makeup interacts with your body over time, or simply the time it took to find the right tests [1].
What is Sideroblastic Anemia?
To understand this condition, it helps to look at how your body builds hemoglobin—the protein in red blood cells that carries oxygen. This process requires a precise dance of iron and other building blocks inside your mitochondria (the powerhouses of your cells) [5].
In your case, a genetic change disrupts this process. Instead of being incorporated into hemoglobin efficiently, iron gets trapped inside the mitochondria [5][6]. Under a microscope with a special stain, these iron-laden red blood cell precursors (erythroblasts) show iron granules encircling the nucleus; doctors call these ring sideroblasts [7][8].
Because the iron is stuck, your body cannot make enough healthy red blood cells. This leads to ineffective erythropoiesis, a state where your bone marrow is working hard to produce cells, but those cells are defective and die before they can do their job [9].
Why Now? Understanding Adult-Onset
It can be confusing to learn that a genetic condition is only being identified now. There are several reasons why these inherited anemias may be diagnosed in adulthood:
- Variable Expressivity: Even people with the same genetic mutation can have very different symptoms [10]. Some individuals may have variations that allow the body to compensate for years [3].
- Genetic Heterogeneity: There are many different genes (such as SLC25A38 or GLRX5) that can cause this condition [11]. Some specific mutations cause severe anemia in infancy, while others result in a slower, more gradual decline in red blood cell production that only becomes noticeable in adulthood [10][12].
- Diagnostic Overlap: In adults, doctors often first look for more common causes of anemia, such as iron deficiency, vitamin deficiencies, or acquired bone marrow disorders [8][13]. It often takes specialized genetic testing to distinguish a lifelong inherited condition from these more common adult issues [4][11].
The Impact of a Rare Diagnosis
Finding out you have a very rare condition—where some specific gene variants may affect only a small number of families worldwide—can feel isolating [14].
The emotional toll of a delayed diagnosis is significant. Patients often note that limited clinician familiarity with rare anemias contributes to delays and can leave them feeling frustrated [2]. You may have experienced psychosocial distress, anxiety, or a decreased quality of life while waiting for an answer [15][16]. Acknowledging these feelings is a vital part of moving forward with your care team.
Looking Forward
Your diagnosis is the first step toward a management plan tailored to your specific genetic type. Because this condition involves iron accumulation, a major focus of your care will be monitoring for iron overload [12]. This can happen even if you have not had many blood transfusions, because your body’s ineffective blood production signals your digestive system to absorb more iron [17].
Your medical team may include hematologists, geneticists, and potentially other specialists if your specific gene affects other parts of your body, such as your muscles or nerves [18][19]. Understanding the “why” behind your anemia empowers you to advocate for the monitoring and treatments that will best support your long-term health.
Common questions in this guide
What is adult-onset autosomal recessive sideroblastic anemia?
Why can an inherited sideroblastic anemia be diagnosed for the first time in adulthood?
What do ring sideroblasts mean on testing?
Which genes can cause autosomal recessive sideroblastic anemia?
Can sideroblastic anemia cause iron overload without many blood transfusions?
Could this diagnosis explain muscle weakness or nerve symptoms?
Should my siblings or relatives have genetic testing?
Questions to Ask Your Doctor
Curated prompts to bring to your next appointment.
- 1.Which specific gene (such as SLC25A38 or GLRX5) was identified as the cause of my anemia, and how does it affect iron in my mitochondria?
- 2.Why did my symptoms become noticeable or get diagnosed now rather than in childhood?
- 3.Does this diagnosis explain other symptoms I may have, like fatigue, muscle weakness, or nerve issues?
- 4.Are there specific reversible causes, like copper deficiency or certain medications, that were ruled out before confirming this genetic diagnosis?
- 5.What is my current iron level, and do I have signs of iron overload in my organs?
- 6.Should my siblings or other family members be offered genetic counseling for this condition, even if they don't have symptoms?
- 7.How will we monitor the effectiveness of my treatment, and what benchmarks are we looking for in my blood work?
Questions For You
Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.
References
References (19)
- 1
Unstable hemoglobin Montreal II uncovered in an adult with unexplained hemolysis exacerbated by a presumed viral infection: a case report.
Medri C, Méndez A, Hammerer-Lercher A, et al.
Journal of medical case reports 2022; (16(1)):145 doi:10.1186/s13256-022-03374-y.
PMID: 35397565 - 2
Health-Related Quality-of-Life Impacts Associated with Transfusion-Dependent β-Thalassemia in the USA and UK: A Qualitative Assessment.
Drahos J, Boateng-Kuffour A, Calvert M, et al.
The patient 2024; (17(4)):421-439 doi:10.1007/s40271-024-00678-7.
PMID: 38530509 - 3
The phenotypic spectrum of germline YARS2 variants: from isolated sideroblastic anemia to mitochondrial myopathy, lactic acidosis and sideroblastic anemia 2.
Riley LG, Heeney MM, Rudinger-Thirion J, et al.
Haematologica 2018; (103(12)):2008-2015 doi:10.3324/haematol.2017.182659.
PMID: 30026338 - 4
Comprehensive Genomic Analysis Identifies a Diverse Landscape of Sideroblastic and Nonsideroblastic Iron-Related Anemias with Novel and Pathogenic Variants in an Iron-Deficient Endemic Setting.
Sharma P, Bhatia P, Singh M, et al.
The Journal of molecular diagnostics : JMD 2024; (26(5)):430-444 doi:10.1016/j.jmoldx.2024.01.011.
PMID: 38360212 - 5
Characterization of Human and Yeast Mitochondrial Glycine Carriers with Implications for Heme Biosynthesis and Anemia.
Lunetti P, Damiano F, De Benedetto G, et al.
The Journal of biological chemistry 2016; (291(38)):19746-59 doi:10.1074/jbc.M116.736876.
PMID: 27476175 - 6
GLRX5 mutations impair heme biosynthetic enzymes ALA synthase 2 and ferrochelatase in Human congenital sideroblastic anemia.
Daher R, Mansouri A, Martelli A, et al.
Molecular genetics and metabolism 2019; (128(3)):342-351 doi:10.1016/j.ymgme.2018.12.012.
PMID: 30660387 - 7
Causes and Pathophysiology of Acquired Sideroblastic Anemia.
Rodriguez-Sevilla JJ, Calvo X, Arenillas L
Genes 2022; (13(9)) doi:10.3390/genes13091562.
PMID: 36140729 - 8
When Ring Sideroblasts on Bone Marrow Smears Are Inconsistent with the Diagnosis of Myelodysplastic Neoplasms.
Girard S, Genevieve F, Rault E, et al.
Diagnostics (Basel, Switzerland) 2022; (12(7)) doi:10.3390/diagnostics12071752.
PMID: 35885655 - 9
Three siblings with variable degrees of neuromuscular involvement and congenital sideroblastic anemia: A peculiar phenotype and a surprise genotypic explanation.
Salam MAE, Salama K, Selim YMM, et al.
Annals of human genetics 2023; (87(4)):166-173 doi:10.1111/ahg.12505.
PMID: 36916508 - 10
Diagnosis and treatment of sideroblastic anemias: from defective heme synthesis to abnormal RNA splicing.
Cazzola M, Malcovati L
Hematology. American Society of Hematology. Education Program 2015; (2015()):19-25 doi:10.1182/asheducation-2015.1.19.
PMID: 26637696 - 11
Understanding Sideroblastic Anemia: An Overview of Genetics, Epidemiology, Pathophysiology and Current Therapeutic Options.
Abu-Zeinah G, DeSancho MT
Journal of blood medicine 2020; (11()):305-318 doi:10.2147/JBM.S232644.
PMID: 33061728 - 12
Clinical characterization and hematopoietic stem cell transplant outcomes for congenital sideroblastic anemia caused by a novel pathogenic variant in SLC25A38.
Uminski K, Houston DS, Hartley JN, et al.
Pediatric blood & cancer 2020; (67(10)):e28623 doi:10.1002/pbc.28623.
PMID: 32790119 - 13
Diagnostic pitfalls of ESA-resistant anemia due to functional copper deficiency in a dialysis patient: a myelodysplastic syndrome mimic.
Ikegishi Y, Abe R, Maehata A, Takiyama Y
CEN case reports 2026; (15(1)):37 doi:10.1007/s13730-025-01042-w.
PMID: 41591643 - 14
SLC25A38 congenital sideroblastic anemia: Phenotypes and genotypes of 31 individuals from 24 families, including 11 novel mutations, and a review of the literature.
Heeney MM, Berhe S, Campagna DR, et al.
Human mutation 2021; (42(11)):1367-1383 doi:10.1002/humu.24267.
PMID: 34298585 - 15
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: research priorities for ultra-rare inherited bleeding disorders.
Nugent D, Acharya SS, Baumann KJ, et al.
Expert review of hematology 2023; (16(sup1)):55-70 doi:10.1080/17474086.2023.2175661.
PMID: 36920862 - 16
Understanding the Association between Red Blood Cell Transfusion Utilization and Humanistic and Economic Burden in Patients with β-Thalassemia from the Patients' Perspective.
Knoth RL, Gupta S, Perkowski K, et al.
Journal of clinical medicine 2023; (12(2)) doi:10.3390/jcm12020414.
PMID: 36675342 - 17
Sideroblastic anemia associated with multisystem mitochondrial disorders.
Tesarova M, Vondrackova A, Stufkova H, et al.
Pediatric blood & cancer 2019; (66(4)):e27591 doi:10.1002/pbc.27591.
PMID: 30588737 - 18
GLRX5-associated [Fe-S] cluster biogenesis disorder: further characterisation of the neurological phenotype and long-term outcome.
Sankaran BP, Gupta S, Tchan M, et al.
Orphanet journal of rare diseases 2021; (16(1)):465 doi:10.1186/s13023-021-02073-z.
PMID: 34732213 - 19
Clinical Features, Molecular Heterogeneity, and Prognostic Implications in YARS2-Related Mitochondrial Myopathy.
Sommerville EW, Ng YS, Alston CL, et al.
JAMA neurology 2017; (74(6)):686-694 doi:10.1001/jamaneurol.2016.4357.
PMID: 28395030
This page is for informational purposes only and does not constitute medical advice about adult-onset autosomal recessive sideroblastic anemia. Your hematologist and genetics team should interpret your genetic results, iron studies, and monitoring plan.
Get notified when new evidence is published on Adult-onset autosomal recessive sideroblastic anemia.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.